Published in Medical Patent Week, April 8th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at NanoLogix.
Report 1: NanoLogix, Inc. (Other OTC:NNLX.PK - News) announced today that it has filed a provisional patent application with the U.S. Patent Office titled, "Antimicrobial Action of a Silver-Coated Nanotubular Dialysis Device."
This provisional patent application is based around a new and unique methodology for treating severe sepsis and septic shock. The incidence of severe sepsis and septic shock is the major factor in over two hundred thousand deaths per year in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week